Welcome to Browse Page of Biomarker

This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.

The total number entries retrieved from this search are 315
Please click on Biomarker_ID to view detailed information.
Note: Potential Biomarker with * indicates these signatures are candidate biomarkers extracted from experiments on mice, rat or cell lines and they are not validated on human patients'cohort.
Biomarker IDBiomarkerBiomoleculeSubjectRegulationBiomarker's typeExperimentLevel of significanceSourcePMID
2324ID2Protein and RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.4) PrognosticHCC with PVI v/s HCC without PVI p < 0.005Tissue17088983
2325API5RNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.49) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2326CTAG1RNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.36) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2327NOLA2RNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.34) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2328DKFZP566D193RNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.3) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2329IMMTRNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.3) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2330DDX1RNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.16) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2331NUDCRNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.14) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2332HT010RNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.14) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2333RANRNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.14) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2334PDHBRNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.13) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2335SCA1RNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.12) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2336PTENP1RNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.11) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2337HFL3RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 2.0) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2338PMS2L11RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.83) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2339SGKRNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.64) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2340GPRK6RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.59) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2341ZNF216RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.54) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2342TIAL1RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.53) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2343KIAA0564RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.48) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2344GADD45BRNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.41) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2345TAPBPRNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.35) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2346RHO6RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.25) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2347SLC9A3R2RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.23) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2348HFL1RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.23) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2349CG018RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.23) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2350PIK3R1RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.22) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2351CYP3A5P2RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.21) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2352LAMP2RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.20) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2353AQP3RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.19) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2354SEMA6CRNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.19) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2355SATRNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.18) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2356PTPRDRNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.15) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2357MASP2RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.15) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2358GADD45BRNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.14) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2360PARD3, INSIG1, MPHOSPH9, SKP2, CUL4B, CETN2, ETS2, USH1C, PTPN11, OASL, ARL5, SMURF2, CDC42SE1, CSNK1G3, RACGAP1, DNAJC10, KCNK1, CDO1, CNGA1, NUDT9, GSTM3, SLC16A5, SARA2, ID2, MTHFD2L, SYNGR2, PRL10A, RNF130, MAFB, FLJ23749, LARP6, R3HDM, ZNF652, PGGT1B, HEXB, SLC27A2, ZBTB38, SH3GLB2, AGPAT3, GCHRNAsHumanDifferentially expressed between recurrence HCC disease PrognosticRecurrent v/s non-recurrent HCC p < 0.05Tissue17975138
2361UBA2RNAsHuman cell lineUpregulated in IFN-alpha drug-tolerant cells Potential Predictive *IFN-α treatment tolerant v/s non tolerant cells FDR <0.5%.Cell line 15709204
2362ZNF185RNAsHuman cell lineUpregulated in IFN-alpha drug-tolerant cells Potential Predictive *IFN-α treatment tolerant v/s non tolerant cells FDR <0.5%.Cell line 15709204
2363FOXF1RNAsHuman cell lineUpregulated in IFN-alpha drug-tolerant cells Potential Predictive *IFN-α treatment tolerant v/s non tolerant cells FDR <0.5%.Cell line 15709204
2364UBE4BRNAsHuman cell lineDownregulated in IFN-alpha drug-tolerant cells Potential Predictive *IFN-α treatment tolerant v/s non tolerant cells FDR <0.5%.Cell line 15709204
2365PFKFB1RNAsHumanUpregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2366G6PCRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2367PCK1RNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2368Fructose-1,6-biphosphataseRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2369NADH dehydrogenase Fe-S protein 8RNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2370NADH dehydrogenase 1-alpha subcomplexRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2371NADH dehydrogenase Fe-S protein 6RNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2372PDHA1/A2/BRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2373GALK1RNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2374GALK2RNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top